Home
ホーム
Our Company
About Us
Leadership
Careers
会社案内
弊社について
リーダーシップ
採用情報
Our Focus
Low Back Pain
Cell Therapy
開発領域
腰痛について
細胞治療
Patients & Families
Degenerative Disc Disease
Clinical Trials
Expanded Access Policy
患者様へ
椎間板変性について
臨床試験情報
Research & Development
Discogenic Cells
IDCT
Product Pipeline
Intellectual Property
Scientific Publications
研究開発
ディスコジェニック細胞について
IDCT
パイプライン
知的財産
出版物
Investors & Media
Press Releases
Events & Presentations
In the News
CEO's Blog
投資家・メディアの方へ
ニュース
イベント情報
ブログ
Contact
お問い合わせ
日本語
English

DiscGenics

Home
ホーム
Our Company
About Us
Leadership
Careers
会社案内
弊社について
リーダーシップ
採用情報
Our Focus
Low Back Pain
Cell Therapy
開発領域
腰痛について
細胞治療
Patients & Families
Degenerative Disc Disease
Clinical Trials
Expanded Access Policy
患者様へ
椎間板変性について
臨床試験情報
Research & Development
Discogenic Cells
IDCT
Product Pipeline
Intellectual Property
Scientific Publications
研究開発
ディスコジェニック細胞について
IDCT
パイプライン
知的財産
出版物
Investors & Media
Press Releases
Events & Presentations
In the News
CEO's Blog
投資家・メディアの方へ
ニュース
イベント情報
ブログ
Contact
お問い合わせ
日本語
English
shutterstock_404152939.jpg

CEO’s Blog

  • Investors & Media
  • Press Releases
  • Events & Presentations
  • In the News
  • CEO's Blog
Featured
May 3, 2023
A Tribute to the Visionary Founders of DiscGenics Inc.
May 3, 2023
Read More →
May 3, 2023
Apr 10, 2020
Keeping Our Patients and Colleagues Safe During the Ongoing COVID-19 Pandemic
Apr 10, 2020

As the COVID-19 pandemic continues to rapidly evolve, our top priority remains the health, safety and well-being of our employees and patients, their families, and our community. I’d like to take a moment to update you on several of the steps we are taking to address this current issue.

Read More →
Apr 10, 2020
Nov 20, 2019
International Journal Publishes DiscGenics-Authored Manuscript on Variability in Cell Therapy
Nov 20, 2019

Regenerative Engineering and Translational Medicine published a DiscGenics-authored manuscript covering sources of variability in cell therapy manufacturing and clinical trials.

Read More →
Nov 20, 2019
Feb 26, 2019
Orders of Magnitude
Feb 26, 2019

Developing a manufactured allogeneic cell therapy requires orders of magnitude of increased rigor over minimally manipulated cells when it comes to not only proving that the product has a therapeutic effect, but also that it meets critical safety standards and is manufactured consistently from lot to lot.

Read More →
Feb 26, 2019
Nov 1, 2018
Combatting the Opioid Crisis with Cell Therapies for Chronic Back Pain
Nov 1, 2018

Opioid addiction is at an all-time high and represents a major public health threat. Our goal at DiscGenics is to develop a cell therapy that eliminates the need for sufferers of chronic low back pain to turn to opioids in the first place.

Read More →
Nov 1, 2018
Sep 26, 2018
What Comes First? Cell Therapy Manufacturing or Clinical Data?
Sep 26, 2018

From my perspective at DiscGenics, investing in the manufacturing process well into the clinical phase is no longer going to be an option for cell and gene therapy developers. Our industry must address the issues related to product manufacturing and quality early in clinical development if cell and gene therapies are truly going to be successful bringing life-altering and, in many cases, life-saving, therapies to patients in the future. 

Read More →
Sep 26, 2018
Sep 12, 2018
RMAT Policy Briefing Takeaways
Sep 12, 2018

Earlier this summer, I attended the Regenerative Medicine Advanced Therapy (RMAT) policy briefing with FDA Commissioner, Dr. Scott Gottlieb, hosted by the Alliance for Regenerative Medicine (ARM) in Washington, D.C. I left the meeting very inspired by Dr. Gottlieb’s leadership and encouraged by the agency’s commitment to fostering greater innovative development in the field of cell and gene therapy. 

Read More →
Sep 12, 2018
Aug 29, 2018
"There’s Got To Be A Better Way"
Aug 29, 2018

How could it be in this age of technology that cutting a patient open so painstakingly and then proceeding to put all this hardware into their back, was really the best and sometimes only option for millions suffering from chronic back pain?

I left that visit thinking: “There’s got to be a better way.”

Read More →
Aug 29, 2018
 
Back to Top

Terms of Use

Privacy Policy